SCHEMBL14029210

SCHEMBL14029210

CNc1nc(SC)ncc1Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.49
KDM4E B2RXH2 1/20 0.49
HTT P42858 2/20 0.44
THRB P10828 1/20 0.42
ADORA2A P29274 2/20 0.42
FYN P06241 1/20 0.42
HSP90AA1 P07900 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
HSD17B10 Q99714 1/20 0.39
NTRK1 P04629 1/20 0.39
PPARG P37231 1/20 0.38
MAPT P10636 1/20 0.38
SRC P12931 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27265275 0.86 KDM4E (0.44) LMNAKDM4EHTTTHRBFYN
SCHEMBL11865948 0.81 L3MBTL1 (0.42) HTTTHRBADORA2AHSP90AA1SMN1; SMN2
SCHEMBL6623077 0.81 LMNA (0.46) LMNAKDM4EHTTTHRBSMN1; SMN2
SCHEMBL16134092 0.79 LMNA (0.40) LMNAKDM4EHTTSMN1; SMN2MAPT
SCHEMBL6619029 0.78 NPC1 (0.44) LMNAKDM4EHTTSMN1; SMN2MAPT
SCHEMBL3965244 0.78 LMNA (0.39) LMNAKDM4EHTTSMN1; SMN2MAPT
SCHEMBL1521589 0.78 HTT (0.51) LMNAKDM4EHTTTHRBSMN1; SMN2
SCHEMBL30346051 0.78 LMNA (0.39) LMNAKDM4EHTTSMN1; SMN2MAPT
SCHEMBL29541506 0.78 LMNA (0.39) LMNAKDM4EHTTSMN1; SMN2MAPT
SCHEMBL1521534 0.78 LMNA (0.39) LMNAKDM4EHTTSMN1; SMN2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7449472-B2 Methods of inhibiting p38 with substituted bicyclic pyrimidines ROCHE PALO ALTO LLC (US) 2008-11-11 US disclosed
US-7439247-B2 Bicyclic pyridine and pyrimidine P38 kinase inhibitors ROCHE PALO ALTOP LLC (US) 2008-10-21 US disclosed